Neurelis Stock

www.neurelis.comBioTechFounded: 2007Funding to Date: $247.94MM

Neurelis is a neuroscience company focusing on the development and commercialization of product candidates for epilepsy and the broader central nervous system market.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Neurelis, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Neurelis in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM